# HCA Healthcare vs Regeneron Pharmaceuticals: stocks compared

URL: https://funkfolio.com/compare/hca-vs-regn

> HCA Healthcare ($104.7B, P/E 16.6) and Regeneron Pharmaceuticals ($99.1B, P/E 21.2) compared: size, valuation, margins, debt, cash and price change.

---

## HCA Healthcare vs Regeneron Pharmaceuticals

HCA Healthcare (HCA), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

HCA Healthcare is worth $104.7B on the stock market and Regeneron Pharmaceuticals $99.1B: HCA Healthcare is valued at 6% more. HCA Healthcare trades at 16.6 times earnings and Regeneron Pharmaceuticals at 21.2. Over the past year HCA Healthcare's share price has moved +7.04% and Regeneron Pharmaceuticals's +31.3%.

### Key facts

- **HCA Healthcare market value:** $104.7B
- **Regeneron Pharmaceuticals market value:** $99.1B
- **HCA Healthcare P/E:** 16.6
- **Regeneron Pharmaceuticals P/E:** 21.2
- **HCA Healthcare revenue:** $75.6B FY to 2025-12-31
- **Regeneron Pharmaceuticals revenue:** $14.3B FY to 2025-12-31
- **Superinvestors holding both:** 2

Market values as of 18 Nov 2026, 00:09 UTC.

HCA Healthcare vs Regeneron Pharmaceuticals: every measure side by side

| Measure | HCA Healthcare | Regeneron Pharmaceuticals |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $104.7B higher | $99.1B lower |
| Revenue | $75.6B higher | $14.3B lower |
| Earnings | $6.8B higher | $4.5B lower |
| Employees | 230,000 higher | 15,410 lower |
| Total assets | $60.7B higher | $40.6B lower |
| Valuation |  |  |
| P/E | 16.6 lower | 21.2 higher |
| P/S | 1.4 lower | 6.9 higher |
| P/B | — | 2.9 |
| Dividend yield | 0.60% higher | 0.39% lower |
| Profitability |  |  |
| Operating margin | — | 24.9% |
| Balance sheet |  |  |
| Net assets | -$6B lower | $31.3B higher |
| Total liabilities | $63.5B higher | $9.3B lower |
| Total debt | $46.5B higher | $2B lower |
| Cash on hand | $1B lower | $3.1B higher |
| Price change |  |  |
| Today | -2.07% lower | +0.56% higher |
| 1 year | +7.04% lower | +31.3% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: HCA Healthcare 105.0, Regeneron Pharmaceuticals 136.0.

- HCA Healthcare (HCA)
- Regeneron Pharmaceuticals (REGN)

HCA Healthcare and Regeneron Pharmaceuticals share prices over one year, rebased to 100: HCA Healthcare ends at 105.0, Regeneron Pharmaceuticals at 136.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | HCA | REGN |
| --- | --- | --- |
| Nov 28, 2025 | 106.5 | 110.8 |
| Dec 31, 2025 | 97.9 | 109.6 |
| Jan 30, 2026 | 102.3 | 105.3 |
| Feb 27, 2026 | 111.0 | 111.0 |
| Mar 31, 2026 | 99.2 | 109.7 |
| Apr 30, 2026 | 91.1 | 100.4 |
| May 29, 2026 | 79.3 | 87.3 |
| Jun 30, 2026 | 81.7 | 88.5 |
| Jul 31, 2026 | 84.4 | 108.3 |
| Aug 31, 2026 | 86.9 | 113.5 |
| Sep 30, 2026 | 89.4 | 107.7 |
| Oct 30, 2026 | 99.2 | 131.7 |
| Nov 17, 2026 | 105.0 | 136.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (2)

- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.6% / 0.3%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.3% / 0.1%

#### HCA Healthcare only (15)

- [Colin Moran](https://funkfolio.com/gurus/colin-moran) 56.5%
- [Andrew Wellington](https://funkfolio.com/gurus/andrew-wellington) 3.8%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 3.6%
- [Matthew McLennan](https://funkfolio.com/gurus/first-eagle) 2.2%
- [Anand Desai](https://funkfolio.com/gurus/anand-desai) 1.9%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.9%
- [Anthony Bozza](https://funkfolio.com/gurus/anthony-bozza) 0.7%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 0.7%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 0.6%
- [Tom Gayner](https://funkfolio.com/gurus/tom-gayner) 0.3%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.1%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) 0.1%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 0.1%
- [Glenn Greenberg](https://funkfolio.com/gurus/glenn-greenberg) &lt;0.1%
- [Temasek](https://funkfolio.com/gurus/temasek) &lt;0.1%

#### Regeneron Pharmaceuticals only (8)

- [Mason Hawkins](https://funkfolio.com/gurus/mason-hawkins) 5.0%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 3.0%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.9%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.5%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.2%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": HCA Healthcare / Regeneron Pharmaceuticals). [Who owns HCA](https://funkfolio.com/stock/HCA/superinvestors) · [Who owns REGN](https://funkfolio.com/stock/REGN/superinvestors)

### More on HCA Healthcare

- [HCA Healthcare (HCA) stock page](https://funkfolio.com/stock/HCA)
- [HCA Healthcare market cap](https://funkfolio.com/stock/HCA/market-cap)
- [HCA Healthcare revenue](https://funkfolio.com/stock/HCA/revenue)
- [HCA Healthcare P/E ratio](https://funkfolio.com/stock/HCA/pe-ratio)
- [HCA Healthcare operating margin](https://funkfolio.com/stock/HCA/operating-margin)
- [HCA Healthcare total debt](https://funkfolio.com/stock/HCA/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Regeneron Pharmaceuticals

- [Regeneron Pharmaceuticals (REGN) stock page](https://funkfolio.com/stock/REGN)
- [Regeneron Pharmaceuticals market cap](https://funkfolio.com/stock/REGN/market-cap)
- [Regeneron Pharmaceuticals revenue](https://funkfolio.com/stock/REGN/revenue)
- [Regeneron Pharmaceuticals P/E ratio](https://funkfolio.com/stock/REGN/pe-ratio)
- [Regeneron Pharmaceuticals operating margin](https://funkfolio.com/stock/REGN/operating-margin)
- [Regeneron Pharmaceuticals total debt](https://funkfolio.com/stock/REGN/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### HCA Healthcare against its closest peers

- [HCA Healthcare vs GSK](https://funkfolio.com/compare/gsk-vs-hca)
- [HCA Healthcare vs CVS Health](https://funkfolio.com/compare/cvs-vs-hca)
- [HCA Healthcare vs Moderna](https://funkfolio.com/compare/hca-vs-mrna)
- [HCA Healthcare vs Sanofi](https://funkfolio.com/compare/hca-vs-sny)

#### Regeneron Pharmaceuticals against its closest peers

- [Regeneron Pharmaceuticals vs Elevance Health](https://funkfolio.com/compare/elv-vs-regn)
- [Regeneron Pharmaceuticals vs GSK](https://funkfolio.com/compare/gsk-vs-regn)
- [Regeneron Pharmaceuticals vs CVS Health](https://funkfolio.com/compare/cvs-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, HCA Healthcare or Regeneron Pharmaceuticals?**

By market value, HCA Healthcare is the larger: $104.7B against $99.1B for Regeneron Pharmaceuticals. By revenue in its latest fiscal year, HCA Healthcare is the larger: $75.6B against $14.3B for Regeneron Pharmaceuticals.

**Which has the higher P/E ratio?**

Regeneron Pharmaceuticals: 21.2, against 16.6 for HCA Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher dividend yield?**

HCA Healthcare: 0.60%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

HCA Healthcare: $46.5B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both HCA Healthcare and Regeneron Pharmaceuticals?**

In their latest 13F filings, Josef Lakonishok and Ray Dalio (founder) hold both.

### Cite this page

Funkfolio, “HCA Healthcare vs Regeneron Pharmaceuticals”, data as of 18 November 2026. https://funkfolio.com/compare/hca-vs-regn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
